<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39198643</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>633</Volume><Issue>8031</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Fibrin drives thromboinflammation and neuropathology in COVID-19.</ArticleTitle><Pagination><StartPage>905</StartPage><EndPage>913</EndPage><MedlinePgn>905-913</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-024-07873-4</ELocationID><Abstract><AbstractText>Life-threatening thrombotic events and neurological symptoms are prevalent in COVID-19 and are&#xa0;persistent in patients with long COVID experiencing post-acute sequelae of SARS-CoV-2 infection<sup>1-4</sup>. Despite the clinical evidence<sup>1,5-7</sup>, the underlying mechanisms of coagulopathy in COVID-19 and its consequences in inflammation and neuropathology remain poorly understood and treatment options are insufficient. Fibrinogen, the central structural component of blood clots, is abundantly deposited in the lungs and brains of patients with COVID-19, correlates with disease severity and is a predictive biomarker for post-COVID-19 cognitive deficits<sup>1,5,8-10</sup>. Here we show that fibrin binds to the SARS-CoV-2 spike protein, forming proinflammatory blood clots that drive systemic thromboinflammation and neuropathology in COVID-19. Fibrin, acting through its inflammatory domain, is required for oxidative stress and macrophage activation in the lungs, whereas it&#xa0;suppresses natural killer cells, after SARS-CoV-2 infection. Fibrin promotes neuroinflammation and neuronal loss after infection, as well as innate immune activation in the brain and lungs independently of active infection. A&#xa0;monoclonal antibody targeting the inflammatory fibrin domain provides&#xa0;protection from microglial activation and neuronal injury, as well as from thromboinflammation in the lung after infection. Thus, fibrin drives inflammation and neuropathology in SARS-CoV-2 infection, and fibrin-targeting immunotherapy may represent a therapeutic intervention for patients with acute COVID-19 and long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ryu</LastName><ForeName>Jae Kyu</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0002-3992-4011</Identifier><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yan</LastName><ForeName>Zhaoqi</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-9326-2920</Identifier><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Montano</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0353-0037</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael Hulton Center for HIV Cure Research at Gladstone, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sozmen</LastName><ForeName>Elif G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dixit</LastName><ForeName>Karuna</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3583-2512</Identifier><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Suryawanshi</LastName><ForeName>Rahul K</ForeName><Initials>RK</Initials><Identifier Source="ORCID">0000-0001-8374-669X</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsui</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-6016-2867</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael Hulton Center for HIV Cure Research at Gladstone, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helmy</LastName><ForeName>Ekram</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael Hulton Center for HIV Cure Research at Gladstone, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaushal</LastName><ForeName>Prashant</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Molecular Genetics (MIMG), University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Quantitative and Computational Biosciences (QCBio), University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makanani</LastName><ForeName>Sara K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Molecular Genetics (MIMG), University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Quantitative and Computational Biosciences (QCBio), University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deerinck</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>National Center for Microscopy and Imaging Research, Center for Research on Biological Systems, University of California San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer-Franke</LastName><ForeName>Anke</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rios Coronado</LastName><ForeName>Pamela E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Department of Biology, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trevino</LastName><ForeName>Troy N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Min-Gyoung</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tognatta</LastName><ForeName>Reshmi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7460-1843</Identifier><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yixin</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-1135-2805</Identifier><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuck</LastName><ForeName>Renaud</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Lucas</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0005-7794-5736</Identifier><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyajima</LastName><ForeName>Hisao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendiola</LastName><ForeName>Andrew S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-2897-3299</Identifier><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arun</LastName><ForeName>Nikhita</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Brandon</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taha</LastName><ForeName>Taha Y</ForeName><Initials>TY</Initials><Identifier Source="ORCID">0000-0002-7344-7490</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael Hulton Center for HIV Cure Research at Gladstone, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Ayushi</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2940-8926</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacDonald</LastName><ForeName>Eilidh</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aries</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petersen</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-1366-1353</Identifier><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meza Acevedo</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzamora</LastName><ForeName>Maria Del Pilar S</ForeName><Initials>MDPS</Initials><Identifier Source="ORCID">0000-0001-8861-387X</Identifier><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Reuben</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traglia</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kouznetsova</LastName><ForeName>Valentina L</ForeName><Initials>VL</Initials><AffiliationInfo><Affiliation>San Diego Supercomputer Center, University of California San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CureScience Institute, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsigelny</LastName><ForeName>Igor F</ForeName><Initials>IF</Initials><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>San Diego Supercomputer Center, University of California San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CureScience Institute, San Diego, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pico</LastName><ForeName>Alexander R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0001-5706-2163</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Red-Horse</LastName><ForeName>Kristy</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1541-601X</Identifier><AffiliationInfo><Affiliation>Department of Biology, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellisman</LastName><ForeName>Mark H</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0001-8893-8455</Identifier><AffiliationInfo><Affiliation>National Center for Microscopy and Imaging Research, Center for Research on Biological Systems, University of California San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krogan</LastName><ForeName>Nevan J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID-19 Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouhaddou</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Molecular Genetics (MIMG), University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Quantitative and Computational Biosciences (QCBio), University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ott</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5697-1274</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Virology, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael Hulton Center for HIV Cure Research at Gladstone, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID-19 Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chan Zuckerberg Biohub, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greene</LastName><ForeName>Warner C</ForeName><Initials>WC</Initials><Identifier Source="ORCID">0000-0001-9896-8615</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Virology, San Francisco, CA, USA. warner.greene@gladstone.ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael Hulton Center for HIV Cure Research at Gladstone, San Francisco, CA, USA. warner.greene@gladstone.ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. warner.greene@gladstone.ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA. warner.greene@gladstone.ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akassoglou</LastName><ForeName>Katerina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2632-1465</Identifier><AffiliationInfo><Affiliation>Center for Neurovascular Brain Immunology at Gladstone and UCSF, San Francisco, CA, USA. katerina.akassoglou@gladstone.ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, CA, USA. katerina.akassoglou@gladstone.ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA. katerina.akassoglou@gladstone.ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K99 AI163868</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007334</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG064926</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL128503</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 RR028962</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM138780</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL094274</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 NS120055</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K99 NS126707</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 NS126707</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI135990</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 NS097976</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R24 GM137200</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD021784</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9001-31-4</RegistryNumber><NameOfSubstance UI="D005337">Fibrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-32-5</RegistryNumber><NameOfSubstance UI="D005340">Fibrinogen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000711647">long COVID brain fog</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005337" MajorTopicYN="Y">Fibrin</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005340" MajorTopicYN="N">Fibrinogen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="Y">Inflammation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008262" MajorTopicYN="N">Macrophage Activation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>K.A. is listed as an inventor on US patents 7,807,645, 8,569,242, 8,877,195 and 8,980,836, covering fibrin antibodies, submitted by the University of California. K.A. and J.K.R. are listed as co-inventors on US patent 9,669,112 covering fibrin in vivo models, and US patents 10,451,611 and 11,573,222 covering in vitro fibrin assays submitted by Gladstone Institutes. K.A., J.K.R., M.M. and W.C.G. are listed as co-inventors on US patent 12,016,934 covering the COVID-induced thromboinflammation model and US patent application 18/267,710 for use of fibrin immunotherapy in COVID-19 submitted by Gladstone Institutes. K.A. is a co-founder and scientific advisor of Therini Bio. K.A. has served as a consultant for F. Hoffman-La Roche not related to this study. W.C.G. is a co-founder and shareholder in InvisiShield Technologies, but work in this company has no overlap with the topic or findings presented in this paper. M.O. is a founder of DirectBio and is on the scientific advisory board of InvisiShield, but both are scientifically unrelated to this study. The Krogan Laboratory has received research support from Vir Biotechnology, F. Hoffmann-La Roche and Rezo Therapeutics unrelated to this study. N.J.K. has a financially compensated consulting agreement with Maze Therapeutics, is&#xa0;the president and is on the board of directors of Rezo Therapeutics, and is a shareholder in Tenaya Therapeutics, Maze Therapeutics, Rezo Therapeutics, GEn1E Lifesciences and Interline Therapeutics, but all are unrelated to this study. Their interests are managed in accordance with their respective institutions&#x2019; conflict of interest policies. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>23</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39198643</ArticleId><ArticleId IdType="pmc">PMC11424477</ArticleId><ArticleId IdType="doi">10.1038/s41586-024-07873-4</ArticleId><ArticleId IdType="pii">10.1038/s41586-024-07873-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Conway, E. M. et al. Understanding COVID-19-associated coagulopathy. Nat. Rev. Immunol.22, 639&#x2013;649 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje, M. &amp; Iwasaki, A. The neurobiology of long COVID. Neuron110, 3484&#x2013;3496 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich, S. &amp; Nath, A. Nervous system consequences of COVID-19. Science375, 267&#x2013;269 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly, Z. &amp; Topol, E. Solving the puzzle of Long Covid. Science383, 830&#x2013;832 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38386747</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet, M. et al. Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization. Nat. Med.29, 2498&#x2013;2508 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10579097</ArticleId><ArticleId IdType="pubmed">37653345</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene, C. et al. Blood&#x2013;brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat. Neurosci.27, 421&#x2013;432 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId></ArticleIdList></Reference><Reference><Citation>Radke, J. et al. Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19. Nat. Neurosci.27, 409&#x2013;420 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38366144</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, M. H. et al. Microvascular injury in the brains of patients with Covid-19. N. Engl. J. Med.384, 481&#x2013;483 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, M. H. et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain145, 2555&#x2013;2568 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox, S. E. et al. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir. Med.8, 681&#x2013;686 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255143</ArticleId><ArticleId IdType="pubmed">32473124</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud, G. et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature604, 697&#x2013;707 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu, T. M. et al. Acute ischemic stroke during the convalescent phase of asymptomatic COVID-2019 infection in men. JAMA Netw. Open4, e217498 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8063067</ArticleId><ArticleId IdType="pubmed">33885771</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar, L. M. et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci. Rep.41, BSR20210611 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad, M., Blish, C. A., Sallusto, F. &amp; Iwasaki, A. The immunology and immunopathology of COVID-19. Science375, 1122&#x2013;1127 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Davalos, D. &amp; Akassoglou, K. Fibrinogen as a key regulator of inflammation in disease. Semin. Immunopathol.34, 43&#x2013;62 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22037947</ArticleId></ArticleIdList></Reference><Reference><Citation>Doolittle, R. F., Yang, Z. &amp; Mochalkin, I. Crystal structure studies on fibrinogen and fibrin. Ann. N. Y. Acad. Sci.936, 31&#x2013;43 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11460486</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu, J. K. et al. Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat. Immunol.19, 1212&#x2013;1223 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6317891</ArticleId><ArticleId IdType="pubmed">30323343</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen, M. A., Ryu, J. K. &amp; Akassoglou, K. Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics. Nat. Rev. Neurosci.19, 283&#x2013;301 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6743980</ArticleId><ArticleId IdType="pubmed">29618808</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva, L. M. et al. Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier. Science374, eabl5450 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34941394</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlini, M. et al. Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer&#x2019;s disease model. Neuron101, 1099&#x2013;1108 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6602536</ArticleId><ArticleId IdType="pubmed">30737131</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendiola, A. S. et al. Defining blood-induced microglia functions in neurodegeneration through multiomic profiling. Nat. Immunol.24, 1173&#x2013;1187 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10307624</ArticleId><ArticleId IdType="pubmed">37291385</ArticleId></ArticleIdList></Reference><Reference><Citation>Long, W. et al. Abnormal fibrinogen level as a prognostic indicator in coronavirus disease patients: a retrospective cohort study. Front. Med.8, 687220 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236504</ArticleId><ArticleId IdType="pubmed">34195213</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E. et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol.20, 172 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y. et al. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. Nature602, 294&#x2013;299 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900207</ArticleId><ArticleId IdType="pubmed">34818667</ArticleId></ArticleIdList></Reference><Reference><Citation>Lijnen, H. R. Elements of the fibrinolytic system. Ann. N. Y. Acad. Sci.936, 226&#x2013;236 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11460480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugarova, T. P. et al. Sequence &#x3b3;377-395(P2), but not &#x3b3;190-202(P1), is the binding site for the &#x3b1;MI-domain of integrin &#x3b1;M&#x3b2;2 in the &#x3b3;C-domain of fibrinogen. Biochemistry42, 9365&#x2013;9373 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12899623</ArticleId></ArticleIdList></Reference><Reference><Citation>Violi, F. et al. Nox2 activation in Covid-19. Redox Biol.36, 101655 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381406</ArticleId><ArticleId IdType="pubmed">32738789</ArticleId></ArticleIdList></Reference><Reference><Citation>Rendeiro, A. F. et al. The spatial landscape of lung pathology during COVID-19 progression. Nature593, 564&#x2013;569 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8204801</ArticleId><ArticleId IdType="pubmed">33780969</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudowska-Sawczuk, M. &amp; Mroczko, B. What is currently known about the role of CXCL10 in SARS-CoV-2 infection? Int. J. Mol. Sci.23, 3673 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8998241</ArticleId><ArticleId IdType="pubmed">35409036</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman, M. et al. Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19. Blood Adv.4, 5035&#x2013;5039 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7594380</ArticleId><ArticleId IdType="pubmed">33075136</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, C. F. et al. Complement receptor 3 has negative impact on tumor surveillance through suppression of natural killer cell function. Front. Immunol.8, 1602 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5702005</ArticleId><ArticleId IdType="pubmed">29209332</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou, M. et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell182, 685&#x2013;712 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7321036</ArticleId><ArticleId IdType="pubmed">32645325</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorkstrom, N. K., Strunz, B. &amp; Ljunggren, H. G. Natural killer cells in antiviral immunity. Nat. Rev. Immunol.22, 112&#x2013;123 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8194386</ArticleId><ArticleId IdType="pubmed">34117484</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank, Z. et al. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin. Infect. Dis.76, e487&#x2013;e490 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu, J. K. et al. Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation. Nat. Commun.6, 8164 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4579523</ArticleId><ArticleId IdType="pubmed">26353940</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully, M. et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N. Engl. J. Med.384, 2202&#x2013;2211 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112532</ArticleId><ArticleId IdType="pubmed">33861525</ArticleId></ArticleIdList></Reference><Reference><Citation>Ols, S. et al. Route of vaccine administration alters antigen trafficking but not innate or adaptive immunity. Cell Rep.30, 3964&#x2013;3971 e3967 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198771</ArticleId><ArticleId IdType="pubmed">32209459</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercade-Besora, N. et al. The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications. Heart110, 635&#x2013;643 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11041555</ArticleId><ArticleId IdType="pubmed">38471729</ArticleId></ArticleIdList></Reference><Reference><Citation>Faksova, K. et al. COVID-19 vaccines and adverse events of special interest: a multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine42, 2200&#x2013;2211 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38350768</ArticleId></ArticleIdList></Reference><Reference><Citation>Akassoglou, K. The immunology of blood: connecting the dots at the neurovascular interface. Nat. Immunol.21, 710&#x2013;712 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7394454</ArticleId><ArticleId IdType="pubmed">32577008</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein, S. R. et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature612, 758&#x2013;763 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarres-Freixas, F. et al. Heterogeneous infectivity and pathogenesis of SARS-CoV-2 variants Beta, Delta and Omicron in transgenic K18-hACE2 and wildtype mice. Front. Microbiol.13, 840757 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9114491</ArticleId><ArticleId IdType="pubmed">35602059</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung, A. L. et al. COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain145, 4193&#x2013;4201 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda, A. et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell185, 2452&#x2013;2468 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, E. et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med.218, e20202135 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli, M., Pujol, J. C., Spector, T. D., Ourselin, S. &amp; Steves, C. J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet399, 2263&#x2013;2264 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryawanshi, R. K. et al. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature607, 351&#x2013;355 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9279157</ArticleId><ArticleId IdType="pubmed">35584773</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunji, Y., Lewis, J. &amp; Gorelik, E. Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells. Blood Coagul. Fibrinolysis1, 663&#x2013;672 (1990).</Citation><ArticleIdList><ArticleId IdType="pubmed">2133246</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerwenka, A. &amp; Lanier, L. L. Natural killer cell memory in infection, inflammation and cancer. Nat. Rev. Immunol.16, 112&#x2013;123 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26806484</ArticleId></ArticleIdList></Reference><Reference><Citation>Muradashvili, N. et al. Fibrinogen-induced increased pial venular permeability in mice. J. Cereb. Blood Flow Metab.32, 150&#x2013;163 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256415</ArticleId><ArticleId IdType="pubmed">21989482</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantor, A. B., Akassoglou, K. &amp; Stavenhagen, J. B. Fibrin-targeting immunotherapy for dementia. J. Prev. Alzheimers Dis.10, 647&#x2013;660 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11227370</ArticleId><ArticleId IdType="pubmed">37874085</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh, T. T. et al. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev.9, 2020&#x2013;2033 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7649481</ArticleId></ArticleIdList></Reference><Reference><Citation>Flick, M. J. et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor &#x3b1;M&#x3b2;2/Mac-1 is critical for host inflammatory response in vivo. J. Clin. Invest.113, 1596&#x2013;1606 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC419487</ArticleId><ArticleId IdType="pubmed">15173886</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadlbauer, D. et al. SARS-CoV-2 seroconversion in humans: a detailed protocol for a serological assay, antigen production, and test setup. Curr. Protoc. Microbiol.57, e100 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7235504</ArticleId><ArticleId IdType="pubmed">32302069</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotaling, N. A., Bharti, K., Kriel, H. &amp; Simon, C. G. Jr. DiameterJ: a validated open source nanofiber diameter measurement tool. Biomaterials61, 327&#x2013;338 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4492344</ArticleId><ArticleId IdType="pubmed">26043061</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates, D., M&#xe4;chler, M., Bolker, B. &amp; Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Softw.67, 1&#x2013;48 (2015).</Citation></Reference><Reference><Citation>Holm, S. A simple sequentially rejective multiple test procedure. Scand. J. Stat.6, 65&#x2013;70 (1979).</Citation></Reference><Reference><Citation>Pettersen, E. F. et al. UCSF Chimera&#x2014;a visualization system for exploratory research and analysis. J. Comput. Chem.25, 1605&#x2013;1612 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Erturk, A. et al. Three-dimensional imaging of solvent-cleared organs using 3DISCO. Nat. Protoc.7, 1983&#x2013;1995 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23060243</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendiola, A. S. et al. Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. Nat. Immunol.21, 513&#x2013;524 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7523413</ArticleId><ArticleId IdType="pubmed">32284594</ArticleId></ArticleIdList></Reference><Reference><Citation>Stopak, K., de Noronha, C., Yonemoto, W. &amp; Greene, W. C. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell12, 591&#x2013;601 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14527406</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegally, H. et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature592, 438&#x2013;443 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33690265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong, Z. et al. Nasally delivered interferon-&#x3bb; protects mice against infection by SARS-CoV-2 variants including Omicron. Cell Rep.39, 110799 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9021357</ArticleId><ArticleId IdType="pubmed">35523172</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, R. E. et al. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature596, 103&#x2013;108 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8349859</ArticleId><ArticleId IdType="pubmed">34153975</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr, T. N. et al. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature597, 97&#x2013;102 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9282883</ArticleId><ArticleId IdType="pubmed">34261126</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevigny, J. et al. The antibody aducanumab reduces A&#x3b2; plaques in Alzheimer&#x2019;s disease. Nature537, 50&#x2013;56 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27582220</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik, E. et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature606, 585&#x2013;593 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9288243</ArticleId><ArticleId IdType="pubmed">35483404</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachs, B. D. et al. p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway. J. Cell Biol.177, 1119&#x2013;1132 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2064370</ArticleId><ArticleId IdType="pubmed">17576803</ArticleId></ArticleIdList></Reference><Reference><Citation>Schachtrup, C. et al. Nuclear pore complex remodeling by p75NTR cleavage controls TGF-&#x3b2; signaling and astrocyte functions. Nat. Neurosci.18, 1077&#x2013;1080 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4878404</ArticleId><ArticleId IdType="pubmed">26120963</ArticleId></ArticleIdList></Reference><Reference><Citation>Davalos, D. et al. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat. Commun.3, 1227 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3514498</ArticleId><ArticleId IdType="pubmed">23187627</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson, M. D. &amp; Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol.11, R25 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2864565</ArticleId><ArticleId IdType="pubmed">20196867</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res.13, 2498&#x2013;2504 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollenus, E. et al. Aspecific binding of anti-NK1.1 antibodies on myeloid cells in an experimental model for malaria-associated acute respiratory distress syndrome. Malar. J.23, 110 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11025177</ArticleId><ArticleId IdType="pubmed">38637828</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrack, K. S. et al. Interleukin-15 complex treatment protects mice from cerebral malaria by inducing Interleukin-10-producing natural killer cells. Immunity48, 760&#x2013;772 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5906161</ArticleId><ArticleId IdType="pubmed">29625893</ArticleId></ArticleIdList></Reference><Reference><Citation>Wensveen, F. M. et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat. Immunol.16, 376&#x2013;385 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25729921</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi, M. et al. MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments. Bioinformatics30, 2524&#x2013;2526 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24794931</ArticleId></ArticleIdList></Reference><Reference><Citation>Turei, D. et al. Integrated intra- and intercellular signaling knowledge for multicellular omics analysis. Mol. Syst. Biol.17, e9923 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7983032</ArticleId><ArticleId IdType="pubmed">33749993</ArticleId></ArticleIdList></Reference><Reference><Citation>Tognatta, R. et al. In vivo two-photon microscopy protocol for imaging microglial responses and spine elimination at sites of fibrinogen deposition in mouse brain. STAR Protoc.2, 100638 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8259313</ArticleId><ArticleId IdType="pubmed">34258598</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro, S. S. &amp; Wilk, M. B. An analysis of variance test for normality (complete samples). Biometrica52, 591&#x2013;611 (1965).</Citation></Reference><Reference><Citation>Brown, M. B. &amp; Forsythe, A. B. Robust tests for the equality of variances. J. Am. Stat. Assoc.69, 364&#x2013;367 (1974).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>